These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18408886)

  • 21. Carnitine/organic cation transporter OCTN2 (Slc22a5) is responsible for renal secretion of cephaloridine in mice.
    Kano T; Kato Y; Ito K; Ogihara T; Kubo Y; Tsuji A
    Drug Metab Dispos; 2009 May; 37(5):1009-16. PubMed ID: 19220985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.
    Seth P; Wu X; Huang W; Leibach FH; Ganapathy V
    J Biol Chem; 1999 Nov; 274(47):33388-92. PubMed ID: 10559218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
    Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
    Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
    Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A
    Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
    Tamai I
    Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional activity of L-carnitine transporters in human airway epithelial cells.
    Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
    Biochim Biophys Acta; 2016 Feb; 1858(2):210-9. PubMed ID: 26607009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
    Tamai I; Ohashi R; Nezu J; Yabuuchi H; Oku A; Shimane M; Sai Y; Tsuji A
    J Biol Chem; 1998 Aug; 273(32):20378-82. PubMed ID: 9685390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative structure activity relationship for inhibition of human organic cation/carnitine transporter.
    Diao L; Ekins S; Polli JE
    Mol Pharm; 2010 Dec; 7(6):2120-31. PubMed ID: 20831193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
    Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
    Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis.
    D'Argenio G; Petillo O; Margarucci S; Torpedine A; Calarco A; Koverech A; Boccia A; Paolella G; Peluso G
    J Biol Chem; 2010 Aug; 285(35):27078-27087. PubMed ID: 20558736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
    Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport of L-carnitine in human corneal and conjunctival epithelial cells.
    Xu S; Flanagan JL; Simmons PA; Vehige J; Willcox MD; Garrett Q
    Mol Vis; 2010 Sep; 16():1823-31. PubMed ID: 21045919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carnitine transport and fatty acid oxidation.
    Longo N; Frigeni M; Pasquali M
    Biochim Biophys Acta; 2016 Oct; 1863(10):2422-35. PubMed ID: 26828774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced L-carnitine transport in aortic endothelial cells from spontaneously hypertensive rats.
    Salsoso R; Guzmán-Gutiérrez E; Arroyo P; Salomón C; Zambrano S; Ruiz-Armenta MV; Blanca AJ; Pardo F; Leiva A; Mate A; Sobrevia L; Vázquez CM
    PLoS One; 2014; 9(2):e90339. PubMed ID: 24587332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.
    Wang Y; Ye J; Ganapathy V; Longo N
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2356-60. PubMed ID: 10051646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2).
    Szabó K; Nagy Z; Juhász V; Zolnerciks JK; Csorba A; Tímár Z; Molnár É; Pádár P; Johnson W; Beéry E; Krajcsi P
    Drug Metab Pharmacokinet; 2017 Jun; 32(3):165-171. PubMed ID: 28365301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel inhibitors of human organic cation/carnitine transporter (hOCTN2) via computational modeling and in vitro testing.
    Diao L; Ekins S; Polli JE
    Pharm Res; 2009 Aug; 26(8):1890-900. PubMed ID: 19437106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells.
    Kobayashi D; Irokawa M; Maeda T; Tsuji A; Tamai I
    Reproduction; 2005 Dec; 130(6):931-7. PubMed ID: 16322553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein phosphatase PP2A - a novel interacting partner of carnitine transporter OCTN2 (SLC22A5) in rat astrocytes.
    Juraszek B; Nałęcz KA
    J Neurochem; 2016 Nov; 139(4):537-551. PubMed ID: 27537937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency.
    Koleske ML; McInnes G; Brown JEH; Thomas N; Hutchinson K; Chin MY; Koehl A; Arkin MR; Schlessinger A; Gallagher RC; Song YS; Altman RB; Giacomini KM
    Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2210247119. PubMed ID: 36343260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.